Genital Warts Surveillance Network

Date Commenced:
02/2008
Project Status
Ongoing
Expected Date of Completion:
Ongoing
Project Supporters

CSL Biotherapies Limitedand Department of Health

Currently recruiting
No
image - Kirby Logo On White 31

About the Project

Aims

The aims of this project are:

  1. To establish a national network of sexual health services to conduct genital wart surveillance 
  2. To enhance the data management systems of the participating sexual health services so that they can routinely transfer surveillance data on genital warts in electronic format to the Kirby Institute
  3. To monitor the diagnosis rates of genital warts
  4. To monitor the characteristics of individuals diagnosed with genital warts
  5. To assess the impact of HPV vaccination programs on the occurrence of genital warts in a variety of populations
Design & Method

The Project involves the collection, analysis and reporting of routinely collected clinical data from nine large sexual health services across Australia. Following information is obtained from all clients attending the participating services: demographics, residency status, sexual behaviour, HPV vaccination status, and past or current diagnosis of genital or anal warts. Data is automatically extracted, line-listed and emailed on a quarterly basis to the Kirby Institute.

Progress/Update

The project is ongoing and continues to receive data from participating services.

Benefits

Accurate estimates of incidence and prevalence are not widely available because genital warts are not a notifiable disease. This ongoing surveillance system measures trends in diagnosis of genital warts, thus filling an important gap in national STI surveillance. In addition, since the quadrivalent HPV vaccine prevents infection of HPV type 6 and 11, the main causes of genital warts, the success of the national HPV vaccination program of the Department of Health and Ageing can be monitored.

Output

A major article detailing the initial findings was published online in 2010. Full citation:

Donovan B, Franklin N, Guy R, Grulich A, Regan DG, Ali H, Wand H, & Fairly CK. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: results of national sentinel surveillance. Lancet Infectious Disease 2011; 11: 39–44.

 

An editorial review described the need for surveillance:

Fairley CK, Donovan B. What can the surveillance of genital warts tell us? Sexual Health2010; 7: 325-327.

Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. Bmj. 2013;346:f2032.

Project Members
image - Basildonovan Head Shoulders 2013
Professor and Program Head
Ph +61 (0)2 9385 9956
image - Rguy
Associate Professor and Program Head
Ph +61 (0)2 9385 0900
image - 1342506122 Hammad Ali 284new
Research Fellow (NHMRC)
Ph +61 (0)2 9385 0912
image - Andrew Grulich2015
Professor and Program Head
Ph +61 (2) 9385 0956
image - 1338426757 David Regan.jpg
Associate Professor
Ph +61 (0)2 9385 0900
image - Handan Wand 220415
Associate Professor
Ph +61 (0)2 9385 0861
image - Rj8a2661 Adjusted Bw
QIP and GRHANITE manager
Ph +61 (0)2 9385 9254
Project Attachment
Other Investigators

Christopher K Fairley

Project Research Area

Project Contacts

Related Projects